Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance therapy with sunitinib in metastatic pancreatic adenocarcinoma
2008-000814-65Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sunitinib in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: PFS-6. Started Mar 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on 2008-000814-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000814-65.